David W Noble
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David W Noble has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alison Avenell
University of Aberdeen
1 shared publication - Anne C Milne
Health Services Research Unit, Health Sciences Building, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK
1 shared publication - Bernard L. Croal
Department of Clinical Biochemistry, Aberdeen University Medical School, Polwarth Building, Aberdeen, AB25 2ZD, UK
1 shared publication - Claire G. Battison
Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK
1 shared publication - Henrik Kehlet
Section for Surgical Pathophysiology, Rigshospitalet, Copenhagen University , Copenhagen
1 shared publication - John Norrie
Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK
1 shared publication
Latest Publications
- Open Access
- 20 September 2007
- Published by Springer Nature in Trials
- Vol. 8 (1) , 25
Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial)
Mortality rates in the Intensive Care Unit and subsequent hospital mortality rates in the UK remain high. Infections in Intensive Care are associated with a 2–3 times increased risk of death. It is thought that under conditions of severe metabolic stress glutamine becomes "conditionally essential". Selenium is an essential trace element that has antioxidant and anti-inflammatory properties. Approximately 23% of patients in Intensive Care require parenteral nutrition and glutamine and selenium are either absent or present in low amounts. Both glutamine and selenium have the potential to influence the immune system through independent biochemical pathways. Systematic reviews suggest that supplementing parenteral nutrition in critical illness with glutamine or selenium may reduce infections and mortality. Pilot data has shown that more than 50% of participants developed infections, typically resistant organisms. We are powered to show definitively whether supplementation of PN with either glutamine or selenium is effective at reducing new infections in critically ill patients.
- 20 September 2007
- Published by Springer Nature in Trials
- Vol. 8 (1) , 25
Open AccessRandomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial)
Mortality rates in the Intensive Care Unit and subsequent hospital mortality rates in the UK remain high. Infections in Intensive Care are associated with a 2–3 times increased risk of death. It is thought that under conditions of severe metabolic stress glutamine becomes "conditionally essential". Selenium is an essential trace element that has antioxidant and anti-inflammatory properties. Approximately 23% of patients in Intensive Care require parenteral nutrition and glutamine and selenium are either absent or present in low amounts. Both glutamine and selenium have the potential to influence the immune system through independent biochemical pathways. Systematic reviews suggest that supplementing parenteral nutrition in critical illness with glutamine or selenium may reduce infections and mortality. Pilot data has shown that more than 50% of participants developed infections, typically resistant organisms. We are powered to show definitively whether supplementation of PN with either glutamine or selenium is effective at reducing new infections in critically ill patients.
- Open Access
- 1 August 2004
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 93 (2) , 178-180
Editorial III: Corticosteroids for septic shock—a standard of care?
Septic shock has a crude mortality rate of 45% and claims the lives of 90 000 people each year in the USA alone.1 An epidemiological study from France of over 100 000 intensive care unit (ICU) admissions indicates the incidence of septic shock before or following admission to ICU is rising and now affects almost 10% of this patient population.2 Given the scale and associated costs of this problem,34 it is not surprising that developing solutions has been a focus of researchers, clinicians, and the pharmaceutical industry. Despite many past disappointments particularly with antagonists of endogenous mediators,5 some recent approaches have shown promise in prevention or treatment of sepsis and septic shock. They include tight glycaemic control, early haemodynamic goal-directed therapy, infusion of activated protein C, and use of corticosteroids.6
- 1 August 2004
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 93 (2) , 178-180
Open AccessEditorial III: Corticosteroids for septic shock—a standard of care?
Septic shock has a crude mortality rate of 45% and claims the lives of 90 000 people each year in the USA alone.1 An epidemiological study from France of over 100 000 intensive care unit (ICU) admissions indicates the incidence of septic shock before or following admission to ICU is rising and now affects almost 10% of this patient population.2 Given the scale and associated costs of this problem,34 it is not surprising that developing solutions has been a focus of researchers, clinicians, and the pharmaceutical industry. Despite many past disappointments particularly with antagonists of endogenous mediators,5 some recent approaches have shown promise in prevention or treatment of sepsis and septic shock. They include tight glycaemic control, early haemodynamic goal-directed therapy, infusion of activated protein C, and use of corticosteroids.6
- 1 May 2003
- Vol. 69 (5) , 447-50
Hypoxia following surgery - an unnecessary cause of morbidity and mortality?
- 1 May 2003
- Vol. 69 (5) , 447-50
Hypoxia following surgery - an unnecessary cause of morbidity and mortality?
Risks of interrupting drug treatment before surgery
Millions of patients worldwide have surgery each year. As well as using a variety of recreational drugs, such as caffeine, tobacco, and alcohol, many of these patients are prescribed therapeutic drugs for concurrent diseases. These drugs are taken for their positive therapeutic benefits, and abrupt interruptions lead at best to a loss of effect and at worst to rebound exacerbations of diseases.1 Unfortunately, surgery, and major abdominal surgery in particular, can cause patients to abstain from their usual drug treatment. After major abdominal surgery gastric emptying is delayed, making administration of drugs by the oral or nasogastric routes unreliable.2-4 Surgical patients may be particularly vulnerable to complications caused by abstention from drug treatment because of the adaptive and maladaptive physiological and psychological stresses related to surgical trauma that may increase the risk of organ dysfunction. 5 6 However, there is little systematic evidence that quantifies the risks of the abrupt withdrawal of therapeutic drugs in the postoperative setting. An observational study by Kennedy and colleagues of over 1000 admissions for general surgery and vascular surgery has made an important preliminary contribution …
Risks of interrupting drug treatment before surgery
Millions of patients worldwide have surgery each year. As well as using a variety of recreational drugs, such as caffeine, tobacco, and alcohol, many of these patients are prescribed therapeutic drugs for concurrent diseases. These drugs are taken for their positive therapeutic benefits, and abrupt interruptions lead at best to a loss of effect and at worst to rebound exacerbations of diseases.1 Unfortunately, surgery, and major abdominal surgery in particular, can cause patients to abstain from their usual drug treatment. After major abdominal surgery gastric emptying is delayed, making administration of drugs by the oral or nasogastric routes unreliable.2-4 Surgical patients may be particularly vulnerable to complications caused by abstention from drug treatment because of the adaptive and maladaptive physiological and psychological stresses related to surgical trauma that may increase the risk of organ dysfunction. 5 6 However, there is little systematic evidence that quantifies the risks of the abrupt withdrawal of therapeutic drugs in the postoperative setting. An observational study by Kennedy and colleagues of over 1000 admissions for general surgery and vascular surgery has made an important preliminary contribution …